Clene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Clene Inc. (CLNN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $17.81 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $17.81.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $19.15.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $20.79.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $21.42.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $17.81 10-Q · filed 2026-08-14 |
| 2026-03-31 | $19.15 10-Q · filed 2026-05-14 |
| 2025-12-31 | $20.79 10-K · filed 2026-03-17 |
| 2025-09-30 | $21.42 10-Q · filed 2025-11-13 |
| 2025-06-30 | $23.93 10-Q · filed 2025-08-14 |
| 2025-03-31 | $24.58 10-Q · filed 2025-05-07 |
| 2024-12-31 | $27.90 10-K · filed 2025-03-24 |
| 2024-09-30 | $28.76 10-Q · filed 2024-11-13 |
| 2024-06-30 | $29.71 10-Q · filed 2024-08-07 |
| 2024-03-31 | $2.22 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.26 10-K · filed 2024-03-13 |
| 2023-09-30 | $2.30 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.33 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.85 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.98 10-K · filed 2023-03-13 |
| 2022-09-30 | $3.53 10-Q · filed 2022-11-07 |
| 2022-06-30 | $3.54 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.52 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.35 10-K · filed 2022-03-11 |
| 2021-09-30 | $3.09 10-Q · filed 2021-11-08 |
| 2020-12-31 | $0.55 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |